Codex DNA (DNAY)
US Market

Codex DNA (DNAY) Stock Price & Analysis


DNAY Stock Chart & Stats

Day’s Range$1.2 - $1.3093
52-Week Range― - ―
Previous Close$1.2
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding29,521,757
10 Day Avg. Volume36,302
30 Day Avg. Volume58,499
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.97
Price to Sales (P/S)2.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside284.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Codex DNA’s price range in the past 12 months?
Currently, no data Available
What is Codex DNA’s market cap?
Currently, no data Available
When is Codex DNA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Codex DNA’s earnings last quarter?
Currently, no data Available
Is Codex DNA overvalued?
According to Wall Street analysts Codex DNA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Codex DNA pay dividends?
    Codex DNA does not currently pay dividends.
    What is Codex DNA’s EPS estimate?
    Codex DNA’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Codex DNA have?
    Currently, no data Available
    What happened to Codex DNA’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Codex DNA?
    Among the largest hedge funds holding Codex DNA’s share is Perceptive Advisors LLC. It holds Codex DNA’s shares valued at N/A.


      Codex DNA Stock Smart Score

      The Codex DNA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Codex DNA

      Codex DNA Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Champions Oncology
      Rapid Micro Biosystems
      Miromatrix Medical
      Science 37

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis